Worldwide will serve as CRO for the Company’s Clinical Programs Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C and Alzheimer’s Disease Cyclo Therapeutics is also ...
GAINESVILLE, Fla.--(BUSINESS WIRE)--Cyclo Therapeutics, Inc. (OTCQB: CTDH), a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback